Elicio Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Elicio Therapeutics, Inc. (ELTX) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.26 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- Elicio Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $753.00K.
- Elicio Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $504.00K, a 12500.00% increase year-over-year.
- Elicio Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$106.00K.
- Elicio Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $344.00K, a 22.52% decline year-over-year.
- Elicio Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$1.15M.
- Elicio Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$835.00K, a 214.54% decline from fiscal 2023.
- Elicio Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $729.00K, a 63.27% decline from fiscal 2022.
- Elicio Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $1.99M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $753.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.26M 10-Q · filed 2026-08-13 | $1.15M derived: sum of 3 quarters · filed 2026-08-13 | $1.50M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $504.00K 10-Q · filed 2026-05-11 | $398.00K derived: sum of 2 quarters · filed 2026-05-11 | $742.00K derived: sum of 3 quarters · filed 2026-05-11 | -$649.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $238.00K derived: sum of 2 quarters · filed 2026-03-12 | -$1.15M derived: sum of 3 quarters · filed 2026-08-13 | -$1.15M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $344.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.05M derived: sum of 2 quarters · filed 2026-08-13 | -$1.04M 10-Q · filed 2025-11-13 | -$2.46M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$1.39M 10-Q · filed 2026-08-13 | -$2.80M derived: sum of 3 quarters · filed 2026-08-13 | -$2.36M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $4.00K 10-Q · filed 2026-05-11 | -$1.41M derived: sum of 2 quarters · filed 2026-05-11 | -$967.00K derived: sum of 3 quarters · filed 2026-05-11 | $254.00K derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | -$1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$971.00K derived: sum of 2 quarters · filed 2026-03-12 | $250.00K derived: sum of 3 quarters · filed 2026-03-12 | -$835.00K 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | $444.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.67M derived: sum of 2 quarters · filed 2025-11-13 | $580.00K 10-Q · filed 2025-11-13 | $1.27M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $136.00K 10-Q · filed 2025-08-07 | $824.00K derived: sum of 3 quarters · filed 2025-08-07 | -$218.00K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | -$1.08M 10-Q · filed 2025-05-13 | -$397.00K derived: sum of 2 quarters · filed 2025-05-13 | -$1.44M derived: sum of 3 quarters · filed 2025-05-13 | -$1.57M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $688.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$354.00K derived: sum of 2 quarters · filed 2025-03-31 | -$486.00K derived: sum of 3 quarters · filed 2025-03-31 | $729.00K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$1.17M derived: sum of 2 quarters · filed 2024-11-13 | $41.00K 10-Q · filed 2024-11-13 | $513.00K derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$132.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.08M 10-Q · filed 2024-08-13 | $1.55M derived: sum of 3 quarters · filed 2024-08-13 | $3.05M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $1.22M 10-Q · filed 2024-05-15 | $766.00K 10-Q · filed 2023-05-10 | $1.69M derived: sum of 2 quarters · filed 2024-05-15 | $3.18M derived: sum of 3 quarters · filed 2024-05-15 | $1.69M derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $472.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $1.97M derived: sum of 2 quarters · filed 2024-03-29 | $470.00K derived: sum of 3 quarters · filed 2024-03-29 | $1.99M 10-K · filed 2024-03-29 | -$806.00K 10-K · filed 2023-03-17 | |||
| 2022-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$2.00K derived: sum of 2 quarters · filed 2023-11-13 | $1.51M 10-Q · filed 2023-11-13 | -$194.00K 10-Q · filed 2022-11-14 | $1.55M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | -$1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $16.00K 10-Q · filed 2023-08-14 | $796.00K 10-Q · filed 2022-08-15 | $50.00K derived: sum of 3 quarters · filed 2023-08-14 | -$685.00K derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $1.51M 10-Q · filed 2023-05-10 | $1.55M derived: sum of 2 quarters · filed 2023-05-10 | $814.00K derived: sum of 3 quarters · filed 2023-05-10 | $166.00K derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | -$701.00K derived: sum of 2 quarters · filed 2023-03-17 | -$1.35M derived: sum of 3 quarters · filed 2023-03-17 | -$4.02M 10-K · filed 2023-03-17 | ||||
| 2021-09-30 | -$735.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.38M derived: sum of 2 quarters · filed 2022-11-14 | -$4.05M 10-Q · filed 2022-11-14 | -$4.60M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$648.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$3.31M 10-Q · filed 2022-08-15 | -$3.86M derived: sum of 3 quarters · filed 2022-08-15 | -$3.54M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | -$2.67M 10-Q · filed 2022-05-16 | -$3.21M derived: sum of 2 quarters · filed 2022-05-16 | -$2.90M derived: sum of 3 quarters · filed 2022-05-16 | -$1.01M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | -$548.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$228.00K derived: sum of 2 quarters · filed 2022-03-30 | $1.65M derived: sum of 3 quarters · filed 2022-03-30 | $2.02M 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $320.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $2.20M derived: sum of 2 quarters · filed 2021-11-12 | $2.57M 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.25M 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | $366.00K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |